4-AMINO-2-FLUORO-N-METHYLBENZAMIDE For Making Enzalutamide CAS Number 915087-25-1
4-AMINO-2-FLUORO-N-METHYLBENZAMIDE For Making Enzalutamide CAS Number 915087-25-1
4-AMINO-2-FLUORO-N-METHYLBENZAMIDE For Making Enzalutamide CAS Number 915087-25-1

1 / 1

4-AMINO-2-FLUORO-N-METHYLBENZAMIDE For Making Enzalutamide CAS Number 915087-25-1

$1.00 ~ $1.00 / Kilogram
Send Inquiry
Model No. : 915087-25-1
Brand Name : VOLSENCHEM
10yrs

Taizhou, Zhejiang, China

Visit The Store
  • Gold Supplier
  • Platform Certification
  • Online Expo

Product description

Enzalutamide intermediate 5 has the full name of  4-AMINO-2-FLUORO-N-METHYLBENZAMIDE CAS number 915087-25-1, it has variety of synthesis method ,here we simply introduce the advantages and disadvantages of various methods. The first: use nitrotoluene derivatives as raw materials by oxidation, acid chloride solution to get the target compound. The biggest drawback of this route is the low yield, even with the most optimistic way to calculate the total yield will not exceed 50%. Followed by the reagent used in production process has big toxicity, will cause greater harm to workers and the environment. The second:use bromobenzofluorobenzoic acid as a raw material through three steps to get the target compound, this route using reagents such as methyl iodide and other methylation reagents, which has big pollution and will bright a lot of hidden danger to production safety. From the current patent report, E There is almost no reference to the experience and ideas of Enzalutamide intermediate 5 CAS 915087-25-1 synthesis method, companies need to spend their time to explore.

Thera. CategoryTreatment of advanced prostate cancer

Cas No. 915087-25-1

Synonym:  N-Methyl-4-amino-2-fluoro-benzamide;4-amino-2-fluoro-N-menthylbenzamide


Enzalutamide Inter 915087-25-1


Molecular Formula:C8H9FN2O

Molecular Weight: 168.17

Assay≥99.%

PackingExport worthy packing

lMaterial Safety Data SheetAvailable on request

Usage:  Enzalutamide (brand name Xtandi) is a nonsteroidal antiandrogen (NSAA) which is used for the treatment of metastatic, castration-resistant prostate cancer (CRPC).[3] An up to 89% decrease in serum prostate specific antigen (PSA) levels have been reported after a month of taking the drug.[4] Research suggests that enzalutamide may also be effective in the treatment of certain types of breast cancer



Send Inquiry

Product Alert

Subscribe to your interested keywords. We will send freely the latest and hottest products to your Inbox. Don't miss any trade information.

版权所有 © 宁波全贸信息技术有限公司 浙ICP备12012821号-1 浙B2-20200628